argenx SE
(NAS:ARGX)
$
863.86
-0.26 (-0.03%)
Market Cap: 55.43 Bil
Enterprise Value: 50.30 Bil
PE Ratio: 32.96
PB Ratio: 6.56
GF Score: 79/100 argenx SE Presents At Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 13, 2021 / 12:00PM GMT
Release Date Price:
$261.28
(+1.19%)
Tazeen Ahmad
BofA Securities, Research Division - VP
Good morning, everybody. Welcome to the third day of the Bank of America Healthcare Conference. Presenting as our next company this morning is argenx. It's always a pleasure to have argenx team members with us. Leading today is going to be Tim Van Hauwermeiren, who we speak to very, very frequently; as well as Keith Woods. Keith and Tim, good morning or good afternoon, depending on where you are.
R. Keith Woods
argenx SE - COO
Good morning, Tazeen.
Timothy Van Hauwermeiren
argenx SE - CEO & Executive Director
Good morning. It's good to see you.
Tazeen Ahmad;Timothy Van Hauwermeiren
BofA Securities, Research Division - VP;argenx SE - CEO & Executive
So maybe we can take a second or 2 to just review where everything that's happened with argenx over the last year, and it's been many things. And from there, we can go into a little bit more detail on questions, if that works.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot